Contributors


Renée Twombly

Latest:

Less is Best: Node Removal Not Necessary in Some Patients

Once again, when it comes to surgery to treat breast cancer, less has been shown to be more.



Dianne Ericson

Latest:

Web Exclusive: The Voice on the Other End of the Phone

Finalist essay from the 2009 Extraordinary Healer Award contest.


Shawn Boink, PT

Latest:

Sharing Our Journey

"We already know how extraordinary she is, and it's time to tell everyone else."


Sandra Allen-Bard

Latest:

Examining Quality of Life Issues for Patients With MPNs

Sandra Allen-Bard, MSN, ANCC, AOCNP, of Weill Cornell Medical Center, discusses the impact myeloproliferative neoplasms can have on patients' quality of life.


Tori Tomalia

Latest:

Listen for Zebras: A ROS1 Lung Cancer Story

ROS1 may be a rare mutation in the cancer world, but a group of ROS1 patients have taken it upon themselves to search for answers.


Paula Anastasia RN, MN, AOCN

Latest:

More Research is Needed to Prevent Late-Stage Diagnosis of Ovarian Cancer

A gynecologic-oncology clinical nurse specialist and one of this year’s CURE Ovarian Cancer Heroes discussed the lack of resources for patients with ovarian cancer and the need for more research.


Jubilee Brown, M.D.

Latest:

Jubilee Brown on Genetic Counseling for Patients With Breast and Ovarian Cancer

Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.


Ian Macleod

Latest:

CURE Community Vlog: Having Great Purpose in Pain After Cancer

“At 34, I have another chance to live the rest of my life with a consciousness that there's great purpose in the pain.”


Cassi Jones

Latest:

Finalist Essay: Advice from the Sky

Finalist essay for CURE's 2013 Extraordinary Healer Award for Oncology Nursing.


Lori Hope

Latest:

Facing Down the Fear

Anxiety is common after cancer, but how do you cope?


Karen Leary

Latest:

A Dynamic Problem Solver

This essay, written by oncology nurse Karen Leary, Ruth & Raymond Perelman Center for Advanced Medicine, nominates fellow registered nurse and colleague Megan Lackaye for CURE®’s 2019 Extraordinary Healer® Award.


James H. Essell, M.D.

Latest:

The History Behind the Development of CAR-T Cell Therapy

These advancements are changing the way many cancers are being treated.


Len Lichtenfeld, M.D.

Latest:

Losing Health Insurance Due to Job Interruption During Pandemic Could Jeopardize Cancer Care for Many Patients

The results of the most recent survey showed that 46% of patients have experienced a decline in their financial security and ability to pay for their care, and nearly 25% worry that they may lose their insurance as a result of the pandemic.


Harvey Max Chochinov, MD PhD

Latest:

To Be or Not To Be: Is That the Right Question?

Distinguishing death with dignity from the right to die movement.


Tracy Posner

Latest:

What Saved Me Years After My Hysterectomy

Life after a hysterectomy is one of the many challenges I have had to overcome.


Josh Hirsch

Latest:

Financial Assistance Programs Offer Out-of-Pocket Cost Relief to Patients with Cancer

Patients faced with cancer are also faced with tough uphill financial battles, but there are assistance programs that can help.


Jason Roberson

Latest:

Acai Berry's Effect on Cancer in Question

Açaí berry’s effect on cancer in question.


Edith Holder

Latest:

Compassion and Kind Ways in Oncology Nursing

An Extraordinary Healer essay honoring MARY McMAHON, RN, OCN [THE CANCER INSTITUTE AT ST. FRANCIS HOSPITAL, EAST HILLS, NEW YORK]


Karuppiah Kannan

Latest:

Karuppiah Kannan on the Past and Future of Myeloma Treatment

Karuppiah Kannan, associate director at Takeda Pharmaceuticals, talks about the progress made in treating myeloma and where the field is going in the future.


Thomas A. Gallo, MS, MDA

Latest:

Building Resiliency in the World of Oncology

As the number of patients and survivors continues to increase, it is important that clinician burnout is handled appropriately, explains Thomas A. Gallo.


Dr. Ian Flinn

Latest:

Revlimid and Rituxan Combo 'Another Potential Option' For Patients With Mantle Cell Lymphoma

“We now have second and third generation cousins of thalidomide that are very useful. So, lenalidomide in combination with rituximab is an effective therapy for mantle cell lymphoma that voids some of these adverse events that I’m talking about,” said Dr. Ian Flinn. Hear more about this treatment in his interview with CURE®.


Jerry A. Barbee Jr., Pharm.D., Glenn Schulman, Pharm.D., Matthew Bailey, Meagan Balding

Latest:

Agents of Choice

Despite a national addiction crisis, opioids remain an appropriate choice for treating severe cancer pain.


Meeri Kim, Ph.D.

Latest:

Beyond the Breast: How Some Patients Combat Brain Metastases

Two women living with metastatic breast cancer that has spread to the brain describe the tools that are helping to keep them alive.


Dr. Scott Irwin

Latest:

How Patients With Cancer Should Approach Questions Surrounding the Final Outcome of COVID-19, Their Diagnosis

“For the patients that are nervous about how this is going to end, or what's going to happen, I would say that that's true for them outside of the COVID crisis because that's the same question they have about their cancer,” Dr. Scott A. Irwin said.



Kara Maxwell

Latest:

Kara Maxwell Explains Breast Cancer Clinical Trials

Kara Maxwell, instructor, medical oncologist, Basser Research Center for BRCA, University of Pennsylvania, explains how a breast cancer clinical trial works.


Regina L. Buchhofer

Latest:

The Good with the Bad

How a paddle replaced anger with joy.


Melissa Gaskill

Latest:

Stem Cells: Helpful or Hurtful?

Stem cells are cells that seem to have the ability to divide perpetually, but what does that mean in cancer?


John Otrompke

Latest:

In Prostate Cancer, Xtandi Sparks More Fatigue and Pain Than Zytiga

Patients treated with Xtandi had higher rates of fatigue and pain than those who were treated with Zytiga and prednisone, resulting in a higher likelihood that they will reduce their treatment dose.